FDA Advisory Committee Recommends Approving First-Ever RSV Vaccine
February 28th 2023Pfizer indicates their RSV vaccine candidate, Abrysvo (RSVpreF), to prevent acute respiratory disease and lower respiratory tract disease caused by respiratory syncytial virus (RSV) in adults 60 years and older by active immunization.
If The PREP Act Sunsets, it Will Affect Pharmacists' Role With Vaccines, Access to Care
February 24th 2023A new report shows these providers are playing a larger role in vaccine administration, but without federal legislation codifying PREP, half the US states could determine not to continue this path for pharmacists and take away this now vital responsibility.
So You Made the Decision to Implement Vancomycin AUC Dosing. Now What?
Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.
Hepatitis B Prevention: We Have the Vaccines, But Not the Implementation
February 22nd 2023Despite effective vaccines and other prevention and treatment modalities, hepatitis B remains a global health challenge. “It’s not for the lack of available tools,” says professor and hepatologist H. Nina Kim, MD, MSc.